ArticleBMC cancer2026

Efficacy and safety analysis of TACE combined with lenvatinib and icaritin in unresectable hepatocellular carcinoma with poor performance status.

Haohao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.